CHARLES J PARKER

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology SALT LAKE CITY, UT NPI 1790735686

General Payments — all program years on this page

$69,287.50

  • Category: General Payments
  • Program years: PY2018–2023
  • Record count: 45
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $15,924.72 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $14,606.803
Travel and Lodging $867.243
Food and Beverage $450.686

By paying entity

Latest program year (PY2023) · sorted by reported total.

Paying entityAmountRecords
Apellis Pharmaceuticals, Inc. $13,186.9210
NOVARTIS PHARMACEUTICALS CORPORATION $2,025.001
F. Hoffmann-La Roche AG $712.801

By program year

Program yearAmountRecords
2018 $15,473.3112
2019 $733.004
2020 $26,760.8910
2021 $6,265.124
2022 $4,130.463
2023 $15,924.7212

Records — PY2023 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1040325685 F. Hoffmann-La Roche AG $712.80 05/09/2023 Consulting Fee Undisputed 01/23/2026 View at CMS
1056306337 Apellis Pharmaceuticals, Inc. $67.80 06/23/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1056309007 Apellis Pharmaceuticals, Inc. $628.80 06/22/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1056313337 Apellis Pharmaceuticals, Inc. $53.50 06/23/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1056355491 Apellis Pharmaceuticals, Inc. $22.98 06/23/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1056356739 Apellis Pharmaceuticals, Inc. $96.08 12/12/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1056360381 Apellis Pharmaceuticals, Inc. $11,869.00 08/04/2023 Consulting Fee Undisputed 01/23/2026 View at CMS
1056364097 Apellis Pharmaceuticals, Inc. $61.10 06/23/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1056374855 Apellis Pharmaceuticals, Inc. $82.37 06/23/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1056376701 Apellis Pharmaceuticals, Inc. $215.46 06/22/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1056377941 Apellis Pharmaceuticals, Inc. $89.83 03/01/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
993438245 NOVARTIS PHARMACEUTICALS CORPORATION $2,025.00 03/04/2023 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.